631 related articles for article (PubMed ID: 37853437)
21. Cancer stem cells: an insight into the development of metastatic tumors and therapy resistance.
Nairuz T; Mahmud Z; Manik RK; Kabir Y
Stem Cell Rev Rep; 2023 Aug; 19(6):1577-1595. PubMed ID: 37129728
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation.
Markopoulos GS; Roupakia E; Marcu KB; Kolettas E
Cells; 2019 Sep; 8(10):. PubMed ID: 31557902
[TBL] [Abstract][Full Text] [Related]
24. Targeting autophagy in cancer stem cells as an anticancer therapy.
Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
[TBL] [Abstract][Full Text] [Related]
25. Cancer Stem Cells: An Ever-Hiding Foe.
Wilczyński JR
Exp Suppl; 2022; 113():219-251. PubMed ID: 35165866
[TBL] [Abstract][Full Text] [Related]
26. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
27. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
Garg M
Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
[TBL] [Abstract][Full Text] [Related]
28. The lipid rafts in cancer stem cell: a target to eradicate cancer.
Zhang S; Zhu N; Li HF; Gu J; Zhang CJ; Liao DF; Qin L
Stem Cell Res Ther; 2022 Aug; 13(1):432. PubMed ID: 36042526
[TBL] [Abstract][Full Text] [Related]
29. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
[TBL] [Abstract][Full Text] [Related]
30. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
Clara JA; Monge C; Yang Y; Takebe N
Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
[TBL] [Abstract][Full Text] [Related]
31. Triptolide inhibits CD133
Acikgoz E; Tatar C; Oktem G
J Cell Biochem; 2020 Jun; 121(5-6):3313-3324. PubMed ID: 31904143
[TBL] [Abstract][Full Text] [Related]
32. The Role of the Renin-Angiotensin System in the Cancer Stem Cell Niche.
Kilmister EJ; Tan ST
J Histochem Cytochem; 2021 Dec; 69(12):835-847. PubMed ID: 34165363
[TBL] [Abstract][Full Text] [Related]
33. [Advances in Lung Stem Cells and Lung Cancer Stem Cells].
Yin H; Deng J
Zhongguo Fei Ai Za Zhi; 2015 Oct; 18(10):633-9. PubMed ID: 26483336
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional regulation of cancer stem cell: regulatory factors elucidation and cancer treatment strategies.
Zhang Z; Zhang Y
J Exp Clin Cancer Res; 2024 Apr; 43(1):99. PubMed ID: 38561775
[TBL] [Abstract][Full Text] [Related]
35. Cancer stem cells and tumor heterogeneity: Deciphering the role in tumor progression and metastasis.
Kapoor-Narula U; Lenka N
Cytokine; 2022 Sep; 157():155968. PubMed ID: 35872504
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
[TBL] [Abstract][Full Text] [Related]
37. Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition.
Jin W
Cells; 2020 Jan; 9(1):. PubMed ID: 31952344
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of the cancer stem cell niche and therapeutic strategies.
Ju F; Atyah MM; Horstmann N; Gul S; Vago R; Bruns CJ; Zhao Y; Dong QZ; Ren N
Stem Cell Res Ther; 2022 Jun; 13(1):233. PubMed ID: 35659296
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells.
Hajizadeh F; Okoye I; Esmaily M; Ghasemi Chaleshtari M; Masjedi A; Azizi G; Irandoust M; Ghalamfarsa G; Jadidi-Niaragh F
Life Sci; 2019 Nov; 237():116952. PubMed ID: 31622608
[TBL] [Abstract][Full Text] [Related]
40. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells.
Bao B; Ahmad A; Li Y; Azmi AS; Ali S; Banerjee S; Kong D; Sarkar FH
Expert Opin Ther Targets; 2012 Oct; 16(10):1041-54. PubMed ID: 22877147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]